Skip to content

Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution

Pilot Study of a Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution

Status
Withdrawn
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04016818
Enrollment
0
Registered
2019-07-12
Start date
2026-06-01
Completion date
2027-12-01
Last updated
2026-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

This is a research study of a novel, "breast-dedicated" positron emission tomography (PET) camera with 1 millimeter spatial resolution. The main goal of the study is for the personnel to understand practical and logistical issues with using the camera in the clinic

Detailed description

Primary Objective To obtain initial experience using the novel, breast-dedicated PET camera design in the breast imaging clinic. Secondary Objectives To understand, given the 10-fold higher sensitivity of this novel camera, how low we can go with administered tracer dose, and, given the \>100-fold better volumetric spatial resolution, understand the achievable image quality.

Interventions

DRUG18F-FDG

Participant will be injected IV (intravenously) with 10 ± 2 mCi of 18F-FDG.

DEVICEBreast-dedicated PET camera

Breast-dedicated PET camera designed by Stanford satellite radiochemistry facility

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Biopsy-confirmed breast cancer measuring ≥ 5 mm on mammogram or ultrasound. * Prior diagnostic imaging test(s) with another modality such as MRI, CT, or x-ray mammography (or other applicable imaging modalities) within 60 days prior to the study date. * Documented written informed consent document.

Exclusion criteria

* 1\. Additional condition, or extenuating circumstance that, in the opinion of the investigator, may interfere with study compliance. * Known allergies to FDG * Pregnant or nursing.

Design outcomes

Primary

MeasureTime frameDescription
Image quality with the breast-dedicated PET camera1 dayFeasibility of the pilot breast-dedicated PET camera will be assessed on the basis of whether acceptable images are obtained. Images will be assessed and graded as 1 of 3 quality ratings: excellent, good, and poor. The outcome will be reported as the number of images that are excellent, good, and poor, a number without dispersion.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORWendy B DeMartini

Stanford University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 30, 2026